-
Permira affiliate to buy small molecule company Cambrex for $2.4bn
pharmaceutical-technology
August 08, 2019
An affiliate of private equity firm Permira Funds is set to acquire small molecule company Cambrex in a deal valued at approximately $2.4bn.
-
Permira Funds to Acquire Cambrex in $2.4B Transaction
contractpharma
August 08, 2019
To back Cambrex in its next phase of growth.
-
Cambrex Expands Process Development at Edinburgh Facility
contractpharma
July 31, 2019
Doubles current footprint to 15,000 sq. ft., adding lab space to accommodate 40 more scientists.
-
Cambrex Makes Senior Appointments
contractpharma
July 01, 2019
New roles to further support the company’s CDMO business.
-
Cambrex Completes New Process and Analytical Development Facility
contractpharma
June 05, 2019
Located at its Karlskoga, Sweden manufacturing site.
-
Cambrex Completes Highly Potent API Mfg. Site
contractpharma
April 15, 2019
Investment in Charles City, IA site totaled $24 million.
-
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
pharmafocusasia
November 28, 2018
Cambrex Corporation, a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced......
-
Acquisition boosts Cambrex's early-stage development capabilities
cphi-online
November 27, 2018
Avista is a portfolio company of Ampersand Capital Partners, a leading healthcare-focused private equity firm. With this acquisition, Cambrex will enter the large and growing market
-
Cambrex adds Avista Pharma to the fold in $250M deal
fiercepharma
November 26, 2018
CDMO Cambrex likes its deals big or small. In September it closed the $425 million deal acquisition of Halo Pharma. This week it is buying a four-facility competitor in a $250 million deal.
-
Cambrex to create process development and clinical supply center of excellence
cphi-online
November 15, 2018
Cambrex is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina. Cambrex will acquire its currently...